A phase I study of153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.
| Autor: | Dispenzieri, A1,2 dispenzieri.angela@mayo.edu, Wiseman, G A3, Lacy, M Q1, Litzow, M R1, Anderson, P M1,4, Gastineau, D A1,5, Tefferi, A1, Inwards, D J1, Micallef, I N M1, Ansell, S M1, Porrata, L1, Elliott, M A1, Lust, J A1,2, Greipp, P R1,6, Rajkumar, S V1,6, Fonseca, R7, Witzig, T E1,6, Erlichman, C8, Sloan, J A9, Gertz, M A1 |
|---|---|
| Zdroj: | Leukemia (08876924). Jan2005, Vol. 19 Issue 1, p118-125. 8p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|